Resolutions at Getinge’s Annual General Meeting

At the Annual General Meeting of Getinge AB held on 20 March 2014, the following
was resolved.

Election of Board of Directors

Carl Bennet (Chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Johan
Malmquist, Johan Stern and Maths Wahlström were re-elected as members of the
Board. Malin Persson was elected new member of the Board.

Malin Persson, born 1968, has a Master of Science in Industrial Engineering and
Management and is CEO of Chalmers University of Technology Foundation. Malin
Persson has many years of experience from large Swedish industrial companies,
including the Volvo Group. Malin Persson is currently member of the Boards of
Becker Industrial Coating, Hexpol AB and Konecranes Plc, and has previously been
chairman of the Board of Elicit AB and Board member of GreenCargo AB.

Fees to the Board of Directors

It was resolved that remuneration to the Board of Directors shall amount to a
total of SEK 4,400,000 excluding remuneration for Committee work, of which SEK
1,100,000 to the Chairman and SEK 550,000 to each of the other Board members
elected by the Meeting who are not employees of Getinge Group. In addition
hereto, the Meeting resolved that work in the Audit Committee shall be
compensated with SEK 240,000 to the Chairman and SEK 120,000 to each of the
other members, while work in the Remuneration Committee work shall be
compensated with SEK 125,000 to the Chairman and SEK 92,000 to each of the other
members.

Dividend

In accordance with the proposal of the Board of Directors and the CEO, the
Annual General Meeting resolved to declare a dividend of SEK 4.15 per share.
Tuesday 25 March 2014 was determined as record date for dividend.

Guidelines for Remuneration to Senior Executives

The Annual General Meeting approved the proposal of the Board regarding
guidelines for remuneration to senior executives, which principally involve the
following. Remuneration and other terms and conditions of employment for senior
executives shall be based on market conditions and be competitive in all markets
where Getinge operates, to ensure that competent and skilful employees can be
attracted, motivated and retained. The total remuneration to senior executives
shall comprise basic salary, variable remuneration, pensions and other benefits.
The variable remuneration shall be limited and connected to predetermined and
measurable criteria elaborated with the purpose to promote the long-term added
value of the company. The Board shall retain the right to deviate from the
guidelines if motivated by particular reasons on an individual basis.

Amendments of the Articles of Association

The Annual General Meeting approved the proposal of the Board regarding
amendments to the the Articles of Association entailing the change of the
registered office of the Board to Gothenburg, Västra Götaland County, Sweden
with the possibility to hold General Meetings in the municipality of Halmstad,
Halland County, Sweden and that the Board shall, in addition to any members who,
pursuant to Swedish law, may be appointed other than by a General Meeting of the
Company, comprise of no fewer than three and no more than eight members with a
maximum of eight deputy members.

For further information, please contact:

Johan Malmquist
Ulf Grunander

CEO, Getinge Group                                                         CFO,
Getinge Group

Tel: +46 10 335 00 00                                                       Tel:
+46 10 335 55 80

E-mail: johan.malmquist@getinge.com                             E-mail:
ulf.grunander@getinge.com

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency in healthcare, care and
research. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control in healthcare and
contamination prevention in biotechnology. MAQUET specializes in solutions,
therapies and products for surgical interventions and intensive care.

Getinge AB discloses the information herein in accordance with the Swedish
Securities Market Act and/or the Financial Instruments Trading Act. The
information was submitted for publication on 20 March 2014 at 17.30 CET.